jueves, 6 de febrero de 2020

Novel coronavirus (2019-nCoV) | FDA

Novel coronavirus (2019-nCoV) | FDA

FDA Medical Countermeasures Initiative Update

FDA is working with U.S. Government partners, including CDC, and international partners to closely monitor an outbreak caused by a novel (new) coronavirus first identified in Wuhan City, Hubei Province, China.

Novel coronavirus (2019-nCoV)

FDA is working with U.S. Government partners, including the U.S. Centers for Disease Control and Prevention (CDC), and international partners to closely monitor an outbreak caused by a novel (new) coronavirus first identified in Wuhan City, Hubei Province, China.

On January 27, 2020, FDA announced critical actions to advance development of novel coronavirus medical countermeasures.

As with any emerging public health threat, FDA is collaborating with interagency partners, product developers, international partners, and global regulators to expedite the development and availability of medical products needed to diagnose, treat, mitigate and prevent such outbreaks.

Related links:


What's new

No hay comentarios: